These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 13652743)

  • 21. Prenatal tolbutamide treatment alters plasma glucose and insulin concentrations and negatively affects the postnatal performance of chickens.
    Franssens L; Lesuisse J; Wang Y; De Ketelaere B; Willems E; Koppenol A; Guo X; Buyse J; Decuypere E; Everaert N
    Domest Anim Endocrinol; 2015 Jul; 52():35-42. PubMed ID: 25727896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of tolbutamide on intestinal glucose absorption and blood glucose levels.
    KLIMAS JE; SEARLE GW
    Proc Soc Exp Biol Med; 1958; 98(4):901-2. PubMed ID: 13591381
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effects of various doses of N-4-methylbenzol-sulfonyl-N-butylharnstoff (D860) and of insulin on blood sugar of metabolically healthy rabbits under various conditions (vagotomy, chloralose anesthesia)].
    KONIG A
    Z Gesamte Exp Med; 1959; 131(2):131-8. PubMed ID: 13648514
    [No Abstract]   [Full Text] [Related]  

  • 24. Population-based modeling to demonstrate extrapancreatic effects of tolbutamide.
    Rostami-Hodjegan A; Peacey SR; George E; Heller SR; Tucker GT
    Am J Physiol; 1998 Apr; 274(4):E758-71. PubMed ID: 9575839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma insulin activity in human diabetes during hypoglycemic response to tolbutamide and indole-3-acetic acid.
    SELTZER HS; SMITH WL
    Proc Soc Exp Biol Med; 1959 Jan; 100(1):171-4. PubMed ID: 13634074
    [No Abstract]   [Full Text] [Related]  

  • 26. [Influence of therapy on glucose and lipid metabolism as well as insulin secretion in diabetes mellitus].
    Lohmann D; Verlohren HJ; Pohl A; Brückner U
    Dtsch Z Verdau Stoffwechselkr; 1976; 36(2):77-84. PubMed ID: 1017406
    [No Abstract]   [Full Text] [Related]  

  • 27. Hypoglycemic and antihyperglycemic effect of leaves of Vinca rosea linn.
    Chattopadhyay RR; Sarkar SK; Ganguly S; Banerjee RN; Basu TK
    Indian J Physiol Pharmacol; 1991 Jul; 35(3):145-51. PubMed ID: 1791053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of tolbutamide, glyburide and glipizide administered supraspinally on CA3 hippocampal neuronal cell death and hyperglycemia induced by kainic acid in mice.
    Kim CH; Park SH; Sim YB; Kim SS; Kim SJ; Lim SM; Jung JS; Suh HW
    Brain Res; 2014 May; 1564():33-40. PubMed ID: 24713348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of the effects of tolazamide and tolbutamide upon blood glucose and serum insulin and lipid levels in diabetic subjects.
    Moorhouse JA
    Can Med Assoc J; 1967 Mar; 96(9):536-9. PubMed ID: 6019354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pioglitazone increases insulin sensitivity, reduces blood glucose, insulin, and lipid levels, and lowers blood pressure, in obese, insulin-resistant rhesus monkeys.
    Kemnitz JW; Elson DF; Roecker EB; Baum ST; Bergman RN; Meglasson MD
    Diabetes; 1994 Feb; 43(2):204-11. PubMed ID: 8288044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Extrapancreatic effects of sulfonylurea compounds. IV. Increase of the effect of insulin due to tolbutamide, glibornuride, and glibenclamide in vitro].
    Beyer J; Gather W; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2179. PubMed ID: 4198966
    [No Abstract]   [Full Text] [Related]  

  • 32. Involvement of nitric oxide (NO) in hypoglycaemic activity of tolbutamide.
    Satyanarayana S; Krishnaiah YS; Rao BK
    Indian J Physiol Pharmacol; 1998 Oct; 42(4):551-4. PubMed ID: 10874360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the effect of tolbutamide, glibenclamide, HB 699, and glucose on serum insulin and blood glucose in gastro-enterectomized dogs.
    Bickel M; Geisen K; Schleyerbach R
    Arch Int Pharmacodyn Ther; 1978 Jul; 234(1):118-38. PubMed ID: 101159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Potentiation of the effects of exogenous insulin by N-(4-methylbenzenesulfonyl)-N'-butylurea and N1-n-butylbiguanide in the eviscerated animal].
    CREUTZFELDT W; DEUTICKE U; SOELING HD
    Klin Wochenschr; 1961 Aug; 39():790-5. PubMed ID: 13696432
    [No Abstract]   [Full Text] [Related]  

  • 35. [Synergism between oral diabetics and insulin].
    Consiglio D; Mantia G; Hopps V
    Boll Soc Ital Biol Sper; 1971 Nov; 47(22):737-42. PubMed ID: 5004485
    [No Abstract]   [Full Text] [Related]  

  • 36. [ORAL THERAPY OF DIABETES MELLITUS].
    MOHNIKE G
    Cas Lek Cesk; 1964 Mar; 103():305-11. PubMed ID: 14138939
    [No Abstract]   [Full Text] [Related]  

  • 37. [Extrapancreatic effects of sulfonylurea compounds. I. Studies on the effect of tolbutamide and glibornuride on blood sugar, nonesterified fatty acids, glycerin, lactate and pyruvate in the pancreatectomized dog chronically treated with insulin].
    Beyer J; Cordes U; Krall H; Sell G; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2167. PubMed ID: 4679246
    [No Abstract]   [Full Text] [Related]  

  • 38. [Propranolol and hypoglycemic sulfonamides. Study on insulin secretion and blood sugar].
    Loubathières A; Mariani MM; Ribes G; Chapal J
    C R Seances Soc Biol Fil; 1971; 165(6):1393-7. PubMed ID: 4262051
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of HB 419 on exogenous and endogenous insulin in dogs and rabbits].
    Pfaff W; Schröder HG
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1488-91. PubMed ID: 5394472
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects on blood sugar of a new potent hypoglycemic compound.
    NIELSEN RL; SWANSON HE; TANNER DC; WILLIAMS RH; O'CONNELL M
    AMA Arch Intern Med; 1958 Feb; 101(2):211-5. PubMed ID: 13497317
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.